DUBLIN, Aug. 19, 2014 /PRNewswire/ -- Research and Markets has announced the addition of the "Pharmaceutical Contract Manufacturing - Global Strategic Business Report" report to their offering.
report analyzes the worldwide markets for Pharmaceutical Contract
Manufacturing in US$ Thousand by the following Dosage Forms: Injectables
(Injections, Vials, and IV solutions), Solid Dosage Forms (Tablets and
Capsules), and Liquid & Semi-solid Dosage Forms (Syrups,
Suspensions, Gels, Creams & Ointments).
The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Middle East, and Latin America. Annual estimates and forecasts are provided for the period 2013 through 2020. Also, a seven-year historic analysis is provided for these markets.
Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs.
The report profiles 92 companies including many key and niche players such as:
AAIPharma Services Corporation
Ajinomoto Althea, Inc.
Albany Molecular Research, Inc.
Key Topics Covered:
I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS
Study Reliability and Reporting Limitations
Data Interpretation & Reporting Level
Quantitative Techniques & Analytics
Product Definitions and Scope of Study
II. EXECUTIVE SUMMARY
1. INDUSTRY OVERVIEW
2. MAJOR MARKET TRENDS & ISSUES
3. COMPETITIVE LANDSCAPE
4. SERVICE OVERVIEW
5. RECENT INDUSTRY ACTIVITY
6. FOCUS ON SELECT GLOBAL PLAYERS
7. GLOBAL MARKET PERSPECTIVE
1. THE UNITED STATES
6. REST OF WORLD
IV. COMPETITIVE LANDSCAPE
Total Companies Profiled: 92 The United States (34)
The United Kingdom (9)
Rest of Europe (10)
Asia-Pacific (Excluding Japan) (18)
For more information visit http://www.researchandmarkets.com/research/3gl53c/pharmaceutical